Elucidation of biomarkers to predict the presence of coronary vulnerable plaque

Elucidation of biomarkers to predict the presence of coronary vulnerable plaque - Prediction of vulnerable plaque by biomarkers

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000009806

Enrollment

200

Registered

2013-01-18

Start date

2012-06-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with coronary artery disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients or suspected patients with coronary artery disease who admit to our hospital for cardiac catheterization or PCI

Exclusion criteria

Exclusion criteria: 1. Patients with end-stage renal disease without hemodialysi 2. Patients with bleeding risk or hemostatic disorder 3. Patients with anemia 4. Patients with contrast media allergy 5. Patients with the potential difficulty in manipulation of catheter

Design outcomes

Primary

Measure	Time frame
To establish biomarkers associated with the presence of VP	—

Secondary

Measure	Time frame
1. Prediction of peri-procedural myocardial injury by biomarkers and intracoronary imaging modality 2. To evaluate the association between biomarkers and indices of vascular function 3. Prediction of VP by the combination of biomarkers and intracoronary imaging modality	—

Countries

Japan

Outcome results